Task: Answer the multiple choice question.
Query: Which drug exhibits a -14.179% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CCC(C(=O)OC)n1cnc2c(nnn2-c2ccc(F)cc2)c1=O
b: O=C(COC(=O)CCc1nc2ccccc2c(=O)[nH]1)NC(c1ccccc1)c1ccccc1
Answer: a. CCC(C(=O)OC)n1cnc2c(nnn2-c2ccc(F)cc2)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C(=O)OC)n1cnc2c(nnn2-c2ccc(F)cc2)c1=O
CCC(C(=O)OC)n1cnc2c(nnn2-c2ccc(F)cc2)c1=O
methyl2-[3-(4-fluorophenyl)-7-oxotriazolo[4,5-d]pyrimidin-6-yl]butanoate